EHA 2019 | Blinatumomab for pediatric ALL

Sara Ghorashian

Sara Ghorashian, PhD, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK, discusses the use of Leukemia Network data in pediatric acute lymphoblastic leukemia (ALL) to demonstrate the efficacy and low toxicity of blinatumomab at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

Share this video